Due to the small size of the electrical lines that reach into the patient’s grey matter, the FDA is also concerned about possible complications if the device needs to be removed wholesale, either for replacement or updates. The leads are so little and sensitive that they risk breaking off during removal (or even normal use) and migrating to other sections of the brain, where they may become trapped in something essential.
